Senior Director, Oncology Clinical Development Leader

Alpha Clinical Laboratory Inc; Boston (MA); On-site; USD 180,000 - 260,000; Full time

Job summary

Alpha Clinical Laboratory Inc. seeks a Sr. Clinical Development Leader in Boston to guide clinical deliverables for a pharmaceutical program.

You will shape development strategy, collaborate with teams across pharmacology, toxicology, operations and regulatory affairs, and manage external outsourcing to ensure timely, on-budget execution. The role requires a Doctorate (MD) preferred with oncology training and 10–15 years in clinical development, including regulatory writing and interactions with

Qualifications

• Doctorate degree MD preferred with training in oncology.
• Minimum of 10–15 years of industry experience; with a minimum of 10 years of clinical Development experience.
• Experience leading and coordinating the clinical drug development activities of at least one approved product or program.
• Experience leading cross-functional teams and handling regulatory and non-regulatory documentation.

Responsibilities

• Provide clinical leadership and strategic medical input for clinical deliverables within the project or program.
• Lead development strategy for assigned targets and collaborate across clinical pharmacology, toxicology, operations and regulatory affairs.
• Oversee outsourcing implementation including vendor/CRO selection to operationalize clinical development.
• Interact with FDA and other regulators; write and review regulatory study documents.

Skills

MD degree

Oncology training

Clinical development

Cross-functional leadership

Regulatory documentation

Education

MD preferred

Job description

Alpha Clinical Laboratory Inc. seeks a Sr. Clinical Development Leader in Boston to guide clinical deliverables for a pharmaceutical program.

You will shape development strategy, collaborate with teams across pharmacology, toxicology, operations and regulatory affairs, and manage external outsourcing to ensure timely, on-budget execution. The role requires a Doctorate (MD) preferred with oncology training and 10–15 years in clinical development, including regulatory writing and interactions with